Oral Malignant Non-Hodgkin Lymphoma: A Retrospective Single-Center Study

Int J Environ Res Public Health. 2022 Feb 24;19(5):2605. doi: 10.3390/ijerph19052605.

Abstract

This study aimed to retrospectively evaluate the incidence of oral non-Hodgkin lymphoma (NHL) in patients referred to the Academic Hospital of the Magna Graecia University of Catanzaro from 2002 to 2020. A retrospective single-center study was performed. Patients with a histologically confirmed diagnosis of oral NHL were included. Demographic data and clinical parameters were digitally recorded, focusing on the NHL-specific localization and symptomatology. The study sample was evaluated by analyzing descriptive statistics with absolute and relative frequencies. A total of 26 patients with intraoral NHL were identified with a progressive increase in NHL occurrence during the observation period. Clinical manifestations included swelling/mass (80.7%), eventually associated with pain and ulcerations. The most common localizations were in soft tissues: buccal mucosa (38.4%), tongue (19.2%), gingiva (11.5%), cheek (11.5%). Oral NHL is rare. Clinical manifestations were unspecific, so a misdiagnosis could occur. The extranodal B-cell form of oral NHL, particularly diffuse large B-cell lymphoma, was the most common frequent oral NHL in this southern Italian population, with a progressively increased occurrence in almost 20 years.

Keywords: lymphoma non-Hodgkin; mouth; oral neoplasms.

MeSH terms

  • B-Lymphocytes
  • Humans
  • Incidence
  • Lymphoma, Non-Hodgkin* / epidemiology
  • Mouth Mucosa / pathology
  • Retrospective Studies